ProAller 50 mL by Pekana

For treatment of allergies and hay fever. PROALLER drops were developed to treat a wide variety of allergies, including hypersensitivity to house dust, foods, antibiotics, metals and animal hair; hay fever; conjunctivitis and irritation of the eyes and ears; and skin allergies such as atrophic eczema and neurodermatitis. Allergies indicate an extensive intoxification, blocked enzymatic processes and a general disruption of the metabolism. Although the type of allergy varies from patient to patient, each represents the body's attempt to excrete excessive toxins via an alternative pathway because the primary organs (liver, kidneys, intestines, lungs) have reached the saturation point. In fact, neurodermatitis is a textbook example of how the body attempts to excrete via the skin as a last resort. PROALLER drops stimulate hepatic and renal function and clean the blood to help the body excrete toxins that play a key role in the development of allergies. Research shows that Leaky-gut syndrome frequently plays a decisive role in many allergies. When an intestinal tract insufficiency allows undigested food particles or bacteria to enter the bloodstream, a systemic intoxification results that burdens the liver, kidneys and other organs. Therefore, the intestines and other excretory organs must always be treated simultaneously with PEKANA medications to control and eliminate allergies. Similar to allergies, Chronic Fatigue Syndrome indicates a severe systemic, pathogenic intoxification. Although CFS may seem to appear rather suddenly, it takes years to develop and in severe cases may require years to reverse. This debilitating condition -- in which exogenic and endogenic factors such as root canals, mercury from amalgam fillings and intestinal dysbiosis cause a continuous, massive intoxification and organ dysfunction -- can lead to serious degenerative diseases, including various forms of cancer, if not ameliorated. Use of PROALLER drops and complementary therapies can successfully address these problems.

Subscribe